Program Information

A Viable Approach to Patient Specific QA for Spine VMAT SRS Using EPID-Based Dosimetry

Y Song*, P Zhang, J Li, C Burman, M Chan, Memorial Sloan-Kettering Cancer Center, Basking Ridge, NJ

SU-E-T-170 Sunday 3:00:00 PM - 6:00:00 PM Room: Exhibit Hall

Purpose:
VMAT involves multi-parameter modulations, thus presenting multi-dimensional challenges. Here, we present a viable approach to VMAT patient specific QA using EPID-based dosimetry for spine VMAT SRS cases

Methods:
Our spine VMAT SRS plans consisted of two full arcs and were optimized with 6 MV photons for a Varian Trilogy LINAC. The QA plans were computed by resetting all control points to 0° gantry angle while keeping the MLC apertures and corresponding MU weights intact. The dose distribution at the depth of clinical significance was calculated in a solid water phantom. EPIDose (Sun Nuclear Corp) was used to convert MV EPID images into absolute dose in a plane of interest in a homogeneous medium. During measurements, the source-to-detector distance (SDD) was set to 105 cm and the VMAT QA plan was delivered with 600 MU/min. For each QA plan, three measurements were made. The average pass rate (thresholds: 2%/2 mm) was then calculated. In addition, the dose at the isocenter or other points of clinical significance was also measured and the mean was calculated.

Results:
Our current institutional QA acceptance criteria for VMAT plans are: pass rate 90% for 2%/2mm with a dose threshold of 10% and the discrepancy between the measured and planned doses at the isocenter or other points of clinical significance 2%. Our preliminary investigation indicated that the pass rate was normally greater than 95.0% with a total number of valid detection points of ~30000. The dose difference at the point of interest was, in general, around ±1.0 %. Sharp dose gradients were accurately detected at the PTV-cord interface.

Conclusions:
EPID-based dosimetry is real-time and financially viable. It can achieve sub-millimeter dosimetry accuracy without extensive inter-diode interpolations. We believe that EPID-based VMAT dosimetry offers a competitive alternative to other competing dosimetry technologies.

Contact Email